Published in Environ Res on October 01, 1983
Cotton dust-mediated lung epithelial injury. J Clin Invest (1986) 0.90
Pulmonary function analysis in the rabbit following bronchochallenge to causative agents and mediators of the acute byssinotic response. Environ Health Perspect (1986) 0.86
Inflammation in the lungs of rats after deposition of dust collected from the air of wool mills: the role of epithelial injury and complement activation. Br J Ind Med (1990) 0.84
Byssinosis: a review. Thorax (1996) 0.83
Methanol extract of grain dust shows complement fixing activity and other characteristics similar to tannic acid. Environ Health Perspect (1986) 0.78
Vegetable dust and airway disease: inflammatory mechanisms. Environ Health Perspect (1986) 0.75
Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun (1978) 2.57
An ultrastructural staining method for enhancing the size and electron opacity of ferritin in thin sections. J Histochem Cytochem (1972) 2.12
The structural basis of glomerular filtration. Adv Nephrol Necker Hosp (1972) 1.44
The interactions of human complement with interfacially aggregated preparations of human secretory IgA. Immunochemistry (1974) 1.19
Stages in phage R17 infection. V. Phage eclipse and the role of F pili. Virology (1971) 1.17
Activation of the alternative complement pathway by Naegleria fowleri. Infect Immun (1980) 1.12
Immunological studies of human placentae: complement components in immature and mature chorionic villi. Clin Exp Immunol (1980) 1.00
Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol (1982) 0.99
A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases. Diagn Immunol (1986) 0.98
Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases. J Dent Res (1977) 0.97
Histamine release from platelets for assay of byssinogenic substances in cotton mill dust and related materials. Br J Ind Med (1979) 0.97
A postulated mechanism for heparin's potentiation of C1 inhibitor function. Mol Immunol (1982) 0.97
Chemotaxins in cotton mill dust: possible etiologic agent(s) in byssinosis. Am Rev Respir Dis (1981) 0.95
Alkaline bismuth reagent for high resolution ultrastructural demonstration of periodate-reactive sites. J Histochem Cytochem (1972) 0.93
Warfarin sodium therapy for chronic urticaria and angioedema. South Med J (1986) 0.93
Nailfold biopsy in scleroderma and related disorders. Correlation of histologic, capillaroscopic, and clinical data. Arthritis Rheum (1984) 0.92
Continuous negative extrathoracic pressure versus positive end-expiratory pressure in piglets after saline lung lavage. Pediatr Pulmonol (1994) 0.92
An IgG primary sequence exposure theory for complement activation using synthetic peptides. Nature (1979) 0.91
A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses. Clin Immunol Immunopathol (1998) 0.90
Hyaluronic acid-complement interactions--I. Reversible heat-induced anticomplementary activity. Mol Immunol (1985) 0.89
Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev (1979) 0.88
Trichomonas vaginalis: alternative pathway activation of complement. Trans R Soc Trop Med Hyg (1982) 0.88
Evidence for the binding of human serum amyloid P component to Clq and Fab gamma. Mol Immunol (1986) 0.87
Bioassays of smooth muscle contracting agents in cotton mill dust and bract extracts: arachidonic acid metabolites as possible mediators of the acute byssinotic reaction. Environ Res (1983) 0.87
Pulmonary function analysis in the rabbit following bronchochallenge to causative agents and mediators of the acute byssinotic response. Environ Health Perspect (1986) 0.86
Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies. Lab Invest (1983) 0.86
Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway. Mol Immunol (1983) 0.84
Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome. Chest (1991) 0.84
Autosomal dominant polycystic kidney disease with liver and pancreatic involvement in early childhood. Am J Kidney Dis (1989) 0.84
A simplified procedure for the assay of leukocyte chemotaxis. J Reticuloendothel Soc (1980) 0.83
Byssinosis: Release of prostaglandins, thromboxane, and 5-hydroxytryptamine in bronchopulmonary lavage fluid after inhalation of cotton dust extracts. Am J Pathol (1985) 0.83
The effects of human saliva on the hemolytic activity of complement. J Dent Res (1978) 0.83
Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma. J Am Acad Dermatol (1984) 0.82
Membranous glomerulonephritis in a child asymptomatic for hepatitis B virus. Concomitant seropositivity for HBsAG and anti-HBs. Am J Clin Pathol (1981) 0.82
Hyaluronic acid-complement interactions--II. Role of divalent cations and gelatin. Mol Immunol (1985) 0.81
C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities. Immunology (1998) 0.81
Cardiopulmonary effects of high-impulse noise exposure. J Trauma (1997) 0.81
Ultrastructural assessment by colloidal iron of the distribution and localization of anionic sites in human glomerulonephritides. Am J Pathol (1981) 0.81
Methemoglobinemia induced by a benzocaine-based topically administered anesthetic in eight sheep. J Am Vet Med Assoc (1992) 0.81
Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med (1984) 0.80
Gm allotypes in blacks with systemic lupus erythematosus. Hum Immunol (1983) 0.80
Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction. Br J Dermatol (1985) 0.80
Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes. Arch Pathol Lab Med (1976) 0.80
Studies on the pathogenesis of acute inflammation. IX. The influence of hyperosomolality secondary to hyperglycemia upon the acute inflammatory response induced by thermal injury to ear chambers of rabbits. J Clin Invest (1970) 0.80
Cloth ballistic vest alters response to blast. J Trauma (1988) 0.80
Complement activation as a possible in vitro indication of the inflammatory potential of endodontic materials. Oral Surg Oral Med Oral Pathol (1988) 0.79
Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol (1985) 0.79
Characterization of C1 inhibitor binding to neutrophils. Immunology (1991) 0.79
Preparation of saliva samples for immunochemical determinations of immunoglobulins and for assay of lysozyme. Clin Chem (1978) 0.79
Gold nephropathy. Ultrastructural, fluorescent, and energy-dispersive x-ray microanalysis study. Arch Pathol Lab Med (1981) 0.79
Etiopathogenic mechanisms of bronchoconstriction in byssinois--a review. Am Rev Respir Dis (1986) 0.79
Cell-mediated immunity in vitro in atopic dermatitis. Arch Dermatol (1979) 0.78
Maximal exercise performance-impairing effects of simulated blast overpressure in sheep. Toxicology (1997) 0.78
Byssinosis: thromboxane release from human platelets by cotton dust and bract extracts. Arch Environ Health (1985) 0.78
Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva. Mol Immunol (1991) 0.78
Rapid kinetic method for detection of complement-mediated damage to nucleated cells. J Immunol Methods (1981) 0.77
Prediction of carbon monoxide diffusing capacity of the lung in splenectomized sheep. Lab Anim Sci (1991) 0.77
Glomerular anionic site distribution in nonproteinuric rats. A computer-assisted morphometric analysis. Am J Pathol (1985) 0.77
Heparin mediates binding of S-protein/vitronectin to the envelope glycoprotein of the human immunodeficiency virus and CD4. Int Arch Allergy Immunol (1994) 0.77
A rapid ultrastructural embedding procedure for renal biopsy tissue. Kidney Int (1982) 0.77
Activation of human complement by totally human monoclonal antibodies. Mol Immunol (1995) 0.76
Unusual complement-mediated hemolytic kinetics at low ionic strength. Mol Immunol (1985) 0.76
Parotid saliva agglutinins for sheep erythrocytes as a measure of ongoing inflammation in periodontal disease. J Periodontol (1984) 0.76
In vitro response of bovine thoracic duct lymphocyte to phytohaemagglutinin following adult thymectomy. Clin Exp Immunol (1976) 0.76
Byssinosis: In vitro release of prostaglandin and thromboxane from lung tissue and polymorphonuclear leukocytes induced by cotton dust and bract extracts. Environ Res (1985) 0.76
Immunoglobulin E in psoriasis evaluated by paper radioimmunosorbent and paper enzyme-immunosorbent tests. Acta Derm Venereol (1985) 0.76
Middle ear injury in animals exposed to complex blast waves inside an armored vehicle. Ann Otol Rhinol Laryngol Suppl (1989) 0.76
Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions. Mol Immunol (1986) 0.75
An ultrastructural method for the use of polyvinylpyrrolidone and dextrans as electron opaque tracers. J Histochem Cytochem (1977) 0.75
Effects of hypertonic solutions infused intravenously in rabbits. I. Metabolic acidosis and lactic acidemia. J Lab Clin Med (1971) 0.75
Preservation of pulmonary function in the ventilated neonatal piglet with normal lungs. Pediatr Pulmonol (1995) 0.75
Byssinosis: serum immunoglobulin and complement concentrations in cotton mill workers. Arch Environ Health (1986) 0.75
Validation of the PEG-IgG screening test for soluble immune complexes by longitudinal studies in experimental acute serum sickness. J Clin Lab Immunol (1985) 0.75
A kinetic model for the quantitative analysis of complement. J Theor Biol (1974) 0.75
Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets. Pediatr Pulmonol (1996) 0.75
A comparative study of glucose oxidase versus FITC-labeled antibody techniques for the detection of antinuclear antibodies. Diagn Immunol (1984) 0.75
Interaction of dental cements with the complement system. Dent Mater (1989) 0.75
Treatment of acute serum sickness by plasma ultrafiltration. Am J Med Sci (1987) 0.75
Restriction of C1 hemolytic function by human proline-rich salivary proteins. Mol Immunol (1984) 0.75
The complement system. Immunol Ser (1990) 0.75
The partial isolation and function of salivary factors which interact with the complement system: a possible role in mucosal immunity. Adv Exp Med Biol (1978) 0.75
A steady state method of measuring carbon monoxide diffusing capacity of the lung of sheep. Lab Anim Sci (1989) 0.75
Direct and indirect immunofluorescent findings in dermatomyositis. J Cutan Pathol (1985) 0.75
A case of "common variable immunodeficiency" with reduced C2 activity and multiple associations. Clin Immunol Immunopathol (1980) 0.75
The effects of reversing distending pressure sequences in the neonatal piglet. Pediatr Pulmonol (1994) 0.75
Computer-controlled large-animal pulmonary function system. Comput Methods Programs Biomed (1989) 0.75
Serum histamine levels following administration of ultrastructural tracers in three strains of rats. Agents Actions (1978) 0.75
Agglutinins for complement-coated sheep erythrocytes. Nature (1977) 0.75
Brief note. Induction of experimental allergic encephalomyelitis in sheep with purified bovine basic protein and adjuvant. Pathology (1979) 0.75
Fibronectin distribution in nailfold biopsies of scleroderma (systemic sclerosis) patients. Acta Derm Venereol (1985) 0.75
A technique for the isolation of single glomeruli for immunohistochemistry. J Histochem Cytochem (1978) 0.75
Disruption of complement-mediated reactions by insoluble dentifrice ingredients. J Periodontol (1981) 0.75
The effects of aggregated human IgG and IgG-immune complexes on the agglutination of bacteria mediated by non-immunoglobulin salivary agglutinins. Arch Oral Biol (1987) 0.75
Lack of effect of azathioprine on phytohemagglutinin-induced lymphocyte transformation and established delayed cutaneous hypersensitivity. Int Arch Allergy Appl Immunol (1976) 0.75